This Obesity Drug Stock Surges 60% on Phase 3 News
A notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
An introduction to wash sale rules as they apply to dividend ETFs and how to structure trades to preserve tax benefits.
17,220 articlesA notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
As AI reshapes legal work, professors debate its limits in reasoning. This article examines why lawyers already bette...
Investors chase a steady $2,000 monthly dividend income amid evolving rates in 2026. This report outlines the math, c...
Bitcoin ETF inflows topped $1 billion over three days, reviving talk of BTC as a market hedge. Traders weigh the sust...
A widely watched energy- income ETF offers monthly-like payouts but comes with uneven distributions and a yield below...
BlackRock launches a new staked Ethereum trust on Nasdaq, combining price upside with validator yields. The move mark...
Gold back under $5,000 has traders weighing the next ETF move. This report compares key gold ETFs, costs, and what co...
As GBTC’s 1.50% fee persists, the cost compounds for long-horizon investors. This piece compares the drag to cheaper ...
Two global asset managers, two different paths to growth. This analysis pits BlackRock and Invesco against each other...
A notable ETF move has real implications for investors. Burkett Financial's latest stake in JEMA offers insight into ...
XRP’s on-exchange stock fell to a seven-year low while the price stayed rangebound. Analysts cite ETF custody moves a...
The U.S. Treasury has designated SPYM as the default ETF for newborn accounts, depositing a $1,000 contribution into ...